Related Experiment Videos
Neurotensin: an endogenous psychostimulant?
1Laboratoire de Neuropharmacologie et Neurochimie, Institute National de la Santé et de la Recherche Médicale U512, Université Claude Bernard, 8 Avenue Rockefeller, 69373 Lyon Cedex 08, France. aberod@rockefeller.univ-lyon1.fr
Current Opinion in Pharmacology
|January 12, 2002
Summary
Neurotensin, a neuropeptide, influences dopamine regulation. Recent studies suggest neurotensin may have psychostimulant effects, contrasting earlier findings of neuroleptic-like actions, sparking debate on therapeutic applications.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- Neurotensin is a neuropeptide implicated in central nervous system functions.
- Its relationship with dopaminergic pathways is well-established.
- Previous research suggested neuroleptic-like effects, but recent findings challenge this view.
Purpose of the Study:
- To investigate the psychopharmacological effects of endogenous neurotensin.
- To reconcile conflicting data regarding neurotensin's action on the central nervous system.
- To explore the therapeutic potential of modulating neurotensin transmission.
Main Methods:
- Utilized non-peptide neurotensin receptor antagonists.
- Examined the impact on central dopaminergic regulation.
- Analyzed behavioral and neurochemical outcomes.
Main Results:
- Evidence suggests a psychostimulant-like action of endogenous neurotensin.
- Contradicts earlier hypotheses of neuroleptic-like effects.
- Highlights the complex role of neurotensin in dopaminergic signaling.
Conclusions:
- The dual potential effects of neurotensin warrant further investigation.
- Compounds targeting neurotensin transmission may offer novel therapeutic strategies.
- Understanding neurotensin's precise role is crucial for drug development.